The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Back Pain
- Lumbar Disc Herniation
- Pain
- Spinal Diseases
- Surgery
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
150 patients will be included for the prospective cohort study. Patients will be recruited from the Region of Southern Denmark and Capital Region. Participants will undergo MRI scanning of the lumbar spine, fillout a questionnaire and undergo assessment with the two clinical tests. An 8-week follow-...
150 patients will be included for the prospective cohort study. Patients will be recruited from the Region of Southern Denmark and Capital Region. Participants will undergo MRI scanning of the lumbar spine, fillout a questionnaire and undergo assessment with the two clinical tests. An 8-week follow-up will be made with patients completing a questionnaire. The two quantitative clinical tests include: electromyographic measurements using Paraspinal Mapping and pain responses using Quantitative Sensory Pain Testing.
Tracking Information
- NCT #
- NCT03832036
- Collaborators
- Frederiksberg University Hospital
- Center for Rheumatology and Spine Diseases, Frederiksberg Hospital, Denmark
- Odense University Hospital
- Investigators
- Principal Investigator: Johanne B Filtenborg, M.Sc. Spine Centre Southern Denmark Study Director: Berit Schiøttz-Christensen, MD Spine Centre Southern Denmark Study Chair: Søren O'Neill, DC Spine Centre Southern Denmark Study Chair: Kirstine Amris, MD The Parker Institute, Frederiksberg Hospital Study Chair: Gilles Fournier, MD, DC Center for Rheumatology and Spine Diseases, Frederiksberg Hospital Study Chair: Andrew J Haig, MD University of Michigan